<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="index_files/filelist.xml">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>fathia faid</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>fathia faid</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>1967</o:TotalTime>
  <o:LastPrinted>2023-11-02T13:53:00Z</o:LastPrinted>
  <o:Created>2023-11-24T00:20:00Z</o:Created>
  <o:LastSaved>2023-11-24T00:20:00Z</o:LastSaved>
  <o:Pages>15</o:Pages>
  <o:Words>5654</o:Words>
  <o:Characters>32234</o:Characters>
  <o:Lines>268</o:Lines>
  <o:Paragraphs>75</o:Paragraphs>
  <o:CharactersWithSpaces>37813</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="index_files/themedata.thmx">
<link rel=colorSchemeMapping href="index_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-GB</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>AR-SA</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1040178053 9 0 511 0;}
@font-face
	{font-family:Inter;
	mso-font-alt:Calibri;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Lato;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1342237951 33 0 415 0;}
@font-face
	{font-family:Poppins;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:32775 0 0 0 147 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-fareast-language:EN-US;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#1F3763;
	mso-themecolor:accent1;
	mso-themeshade:127;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-fareast-language:EN-US;
	font-weight:normal;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:24.0pt;
	mso-bidi-font-size:24.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:18.0pt;
	mso-ligatures:none;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
span.text-with-replacments
	{mso-style-name:text-with-replacments;
	mso-style-unhide:no;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	mso-ascii-font-family:"Calibri Light";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Calibri Light";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#1F3763;
	mso-themecolor:accent1;
	mso-themeshade:127;}
p.text-gray-500, li.text-gray-500, div.text-gray-500
	{mso-style-name:text-gray-500;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
span.indent--2rem
	{mso-style-name:"indent-\[-2rem\]";
	mso-style-unhide:no;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:54396398;
	mso-list-template-ids:1453372586;}
@list l1
	{mso-list-id:1485271291;
	mso-list-template-ids:489214620;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	mso-fareast-language:EN-US;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink="#954F72" style='tab-interval:.5in;word-wrap:
break-word'>

<div class=WordSection1>

<p><b><span style='font-size:14.0pt'><a href="../Downloads/undefined"><span
style='text-decoration:none;text-underline:none'>speech</span></a> </span></b><a
href="../Downloads/undefined"><b><span style='font-size:14.0pt;text-decoration:
none;text-underline:none'>deficits associated with bilateral thalamotomy in
Parkinson’s disease: effects</span></b></a><b><span style='font-size:14.0pt'> </span></b><a
href="../Downloads/undefined"><b><span style='font-size:14.0pt;text-decoration:
none;text-underline:none'>of intensive voice therapy.</span></b></a><b><span
style='font-size:14.0pt'>(case study during 3years)<o:p></o:p></span></b></p>

<p style='text-align:justify'><span style='font-size:10.5pt;font-family:"Lato",sans-serif;
color:#333333;background:white'>Abstract:</span><span style='font-size:10.5pt;
font-family:Poppins;color:#333333'><br>
</span><span class=GramE><span style='font-size:10.5pt;font-family:"Lato",sans-serif;
color:#333333;background:white'>This structured abstract reviews</span></span><span
style='font-size:10.5pt;font-family:"Lato",sans-serif;color:#333333;background:
white'> the effects of intensive voice therapy on speech deficits in
Parkinson's disease (PD) patients following bilateral thalamotomy. The study
focuses on one case study and explores the use of the Lee Silverman Voice
Treatment (LSVT) in improving speech performance and vocal intensity, as well
as the Voice Handicap Index-10 scores. The paper acknowledges the limitations
of current research and emphasizes the need for a comprehensive understanding
of prognostic variables that may influence therapy outcomes. It also calls for
the development of combined treatment approaches and more advanced delivery
methods, such as smartphone-based video conferencing. Additionally, the paper
highlights the importance of extended research on the effects of intensive
voice therapy, specifically LSVT, on swallowing functions in PD treatment
protocols. While the results indicate promising improvements in speech
problems, further research is needed to fully understand the therapeutic implications
of intensive voice therapy for PD <span class=GramE>patients</span><o:p></o:p></span></p>

<p>Introduction<span style='font-size:10.5pt;font-family:"Lato",sans-serif;
color:#333333;background:white'><o:p></o:p></span></p>

<p>It is Parkinson’s disease where it affects speaking and voice, which <span
class=SpellE>inturn</span> affects the patients <span class=SpellE>abilitym</span>
to communicate effectively and <span class=GramE>socially.<sup>(</sup></span><sup>Yang
et al., 2014)(Perju-<span class=SpellE>Dumbrav&#259;</span> et al., 2017)(Kim
et al., 2020)</sup>Presently, there are some medical remedies for PD but they
have little or no effect with regard to these speech problems.&nbsp;<sup>(Zahid
et al., <span class=GramE>2020)(</span>Haq et al., 2019)(<span class=SpellE>Udow</span>
et al., 2018)<o:p></o:p></sup></p>

<p>Although the role of SLT <span class=SpellE>imanaging</span> speech deficits
among PD patients has proven positive, there has been a limited scope of
research conducted on this matter.&nbsp;<sup>(Perju-<span class=SpellE>Dumbrav&#259;</span>
et al., <span class=GramE>2017)(</span>Silveira &amp; <span class=SpellE>Brasolotto</span>,
2005)</sup>LSVT has demonstrated goo effects in mild and moderate cases of PD,
though it hasn’t been studied sufficiently in initial stage ones.&nbsp;<sup>(Garg
&amp; Dhamija, <span class=GramE>2020)(</span>Scobie et al., 2021)</sup>In
order to manage <span class=SpellE>thecommunication</span> disorders related to
the PD such as dysphonia, tools such as voice handicap index are vital to
enable early identification as they also measure their impact on the patient’s
day-to-day activities.<sup>(<span class=SpellE>Zvrko</span> &amp; Kadi&#263;,
2022)(Pfeifer et al., 2021)</sup></p>

<p>Intervention studies</p>

<p>investigating SLT and LSVT techniques, among others, are ongoing at larger
scales to target speech impairments in PD. Speech difficulties <span
class=SpellE>greatl</span> influence an individual’s psycho-social well-being
thereby, it is crucial to address these <span class=GramE>issues..</span><sup>(Masterson-Algar
et al., 2017)</sup></p>

<p>2. methodology </p>

<p>The purpose of this study was to determine <span class=GramE>whether or not</span>
intense voice therapy would be effective for PD patients who had defective
speech.&nbsp;<sup>(<span class=SpellE>Sackley</span> et al., <span class=GramE>2014)(</span>Masterson-Algar
et al., 2017)</sup></p>

<p>This is a case of degeneration of the nerves which affects approximately 1.5
percent of the population <span class=GramE>globally.<sup>(</sup></span><sup>Costa
et al., 2016)(Lakshmi et al., 2021)</sup>It results in voice or speech problems
causing difficulties with communication.&nbsp;<sup>(Boltežar &amp; Bahar, <span
class=GramE>2014)(</span>Scobie et al., 2021)</sup></p>

<p>These impairments do not respond adequately to current
treatments.&nbsp;Previous studies have suggested SLT as a possible therapy; <span
class=GramE>however;</span> the evidence is marred by questions regarding
methodological errors and publication bias.</p>

<p><sup>(<span class=SpellE>Dankovicova</span> et al., <span class=GramE>2018)(</span>Kulkarni
et al., 2022)</sup> forty five year old female PD patient, with previous
bilateral thalamotomy, was studied in this case study.&nbsp;</p>

<p><span class=SpellE><sup>parkinson</sup></span><sup> S
Disease&quot;,&quot;relevanceScore&quot;:1.3681640625,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Ahlberg et al., 2011)(Fiani et al., 2020)</sup></p>

<p>Pre-treatment presented with decreased loudness, <span class=SpellE>hoaeness</span>,
low pitch, monotonicity, poor articulation, and vocal fatigue.&nbsp;Pre-and
post-treatment data was collected using acoustical measures and perceptual
rating scales.</p>

<p><sup>0.05). All measures detect statistically significant and clinically
important differences between controls and patients, both treated and untreated
(p 0.7). Pre-to post-operation, GRBAS ratings show statistically significant
and clinically important improvement in overall dysphonia grade (G) (AUC =
0.946, p measures may be useful UVFP treatment effectiveness monitoring tools,
and there may be applications for other forms of <span class=SpellE>dysphonia.&quot;,&quot;journal&quot;:&quot;Nature</span>
Precedings&quot;,&quot;relevanceScore&quot;:0.15087890625,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Little et al., 2009)(Perju-<span
class=SpellE>Dumbrav&#259;</span> et al., 2017)</sup></p>

<p>These included improved performances in different elements of speech like
maximum endurance of the sustained vowel phonation, fundamental frequency (F),
voice intensity (I) (Hertz), voice jitter and shimmer, harmonic to noise ratio
(HR/N) (%), and average <span class=GramE>dev</span> </p>

<p><sup>(<span class=SpellE>Ozker</span> et al., 2022)</sup></p>

<p>The result of these findings indicates an <span class=GramE>improvement
speech problems</span> in <span class=SpellE>parkinson</span> disease patients
through intensive voice therapy.&nbsp;Still, one should think about the age,
gender, disease stage, amount of time for diagnosing, degree of the spoken word
disturbance, depression state, and cognitive ability to evaluate the efficiency
of this treatment in the same way.&nbsp;</p>

<p><span class=SpellE><sup>parkinson</sup></span><sup> S
Disease&quot;,&quot;relevanceScore&quot;:0.51025390625,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Ueno et al., 2017)(Cheng &amp; Su, 2020)</sup></p>

<p>More studies should be carried out in order to increase their efficacy
towards improving the lives of those suffering from <span class=GramE>PD</span></p>

<p><sup>(<span class=SpellE>Foltynie</span> &amp; Grover, <span class=GramE>2020)(</span>Chen
et al., 2023)</sup></p>

<p>&nbsp;</p>

<p>3. 2. Case Study Summary</p>

<p>The purpose of this study was to determine <span class=GramE>whether or not</span>
intense voice therapy would be effective for PD patients who had defective
speech.&nbsp;This is a case of degeneration of the nerves which affects
approximately 1.5 percent of the <span class=GramE>population</span></p>

<p><sup>(<span class=SpellE>Goloborshcheva</span> et al., <span class=GramE>2022)(</span>Li
et al., 2022)</sup>globally. </p>

<p>It results in voice or speech problems causing difficulties with
communication.&nbsp;These impairments do not respond adequately to current
treatments.&nbsp;Previous studies have</p>

<p>suggested SLT as a possible therapy; <span class=GramE>however;</span> the
evidence is marred by questions regarding methodological errors and publication
bias.</p>

<p><sup>(<span class=SpellE>Sackley</span> et al., <span class=GramE>2014)(</span><span
class=SpellE>Sackley</span> et al., 2020)</sup></p>

<p>A <span class=GramE>forty five year old</span> female PD patient, with
previous bilateral thalamotomy, was studied in this case
study.&nbsp;Pre-treatment presented with decreased loudness, <span
class=SpellE>hoaeness</span>, low pitch, monotonicity, poor articulation, and
vocal fatigue.&nbsp;Pre-and post-treatment data was collected using acoustical
measures and perceptual rating scales.</p>

<p><sup>0.05). All measures detect statistically significant and clinically
important differences between controls and patients, both treated and untreated
(p 0.7). Pre-to post-operation, GRBAS ratings show statistically significant
and clinically important improvement in overall dysphonia grade (G) (AUC =
0.946, p measures may be useful UVFP treatment effectiveness monitoring tools,
and there may be applications for other forms of <span class=SpellE>dysphonia.&quot;,&quot;journal&quot;:&quot;Nature</span>
Precedings&quot;,&quot;relevanceScore&quot;:0.0792236328125,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Little et al., 2009)</sup></p>

<p>These included <span class=SpellE>improvedperformances</span> in different
elements of speech like maximum endurance of the sustained vowel phonation,
fundamental frequency (F), voice intensity (I) (Hertz), voice jitter and
shimmer, harmonic to noise ratio (HR/N) (%), and</p>

<p><sup>(<span class=SpellE>Nanahara</span> et al., <span class=GramE>2022)<span
style='vertical-align:baseline'>average</span></span></sup> dev</p>

<p>The result of these findings indicates an improvement speech <span
class=GramE>problems</span> in <span class=SpellE>parkinson</span> disease
patients through</p>

<p>intensive voice therapy.&nbsp;Still, one should think about</p>

<p>the age, gender, disease stage, amount of time for diagnosing, degree of the</p>

<p>spoken word disturbance, depression state, and cognitive ability to <span
class=GramE>evaluate</span></p>

<p>the efficiency of this treatment in the same way.&nbsp;More studies should
be <span class=GramE>carried</span></p>

<p>out in order to increase their efficacy towards improving the lives of <span
class=GramE>those</span></p>

<p>suffering from <span class=GramE>PD..</span></p>

<p>4. Review of Existing Literature</p>

<p>The existing literature on intensive voice therapy for speech deficits in
Parkinson's disease provides valuable insights, but there are areas that
require further investigation.</p>

<p><sup>(Stevenson et al., <span class=GramE>2019)(</span>Seidel et al., 2016)</sup></p>

<p>One area is the limited scientific studies on bilaterally induced vocal
deficits in</p>

<p><sup>(Stevenson et al., 2019)</sup></p>

<p>Parkinson's disease. </p>

<p>Most studies have focused on either speech or swallowing, with only one
group examining both. </p>

<p><sup>(Syed et al., 2020)</sup></p>

<p>They found reduced elevation of the tongue during speech and swallowing,
suggesting rigidity rather than weakness.</p>

<p><sup>(Syed et al., 2020)</sup></p>

<p>Another significant finding <span class=SpellE>isthat</span> traditional
speech therapy does not elicit a response from the thalamus. </p>

<p><sup>(Hameed et al., <span class=GramE>2021)(</span>Zahid et al., 2020)</sup></p>

<p>This highlights the need for alternative treatment approaches that can
effectively engage the thalamus. </p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>Intensive voice treatment, specifically the Lee Silverman Voice Treatment
program (LSVT), targets the underlying motor disorder associated with
Parkinson's disease. It focuses on high phonatory effort tasks to increase
vocal fold adduction and respiratory support, improving laryngeal output and
alleviating the effects of hypokinesia.</p>

<p><sup>(Masterson-Algar et al., <span class=GramE>2017)(</span><span
class=SpellE>Crispiatico</span> et al., 2022)</sup></p>

<p>Studies have shown positive outcomes with LSVT, including increased vocal
intensity immediately after treatment compared to placebo speech therapy.
Clinicians have also observed improvements in swallowing during and after
therapy.</p>

<p><span class=SpellE><sup>parkinson</sup></span><sup> S
Disease&quot;,&quot;relevanceScore&quot;:0.75439453125,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Ueno et al., 2017)</sup></p>

<p>&nbsp;Long-term efficacy has been demonstrated, with patients maintaining or
improving vocal intensity up to two years after treatment. Preliminary scans
have shown educed activity in the globus pallidus, suggesting broader effects
beyond the phonatory system.</p>

<p>However, there are limitations in the scope of research. Prognostic
variables and</p>

<p><sup>(Pellecchia et al., 2015)</sup></p>

<p>response to LSVT in individuals with factors like depression and dementia,
as</p>

<p>well as atypical Parkinson's disease, require further investigation.</p>

<p>Alternative methods of delivering therapy, such as webcam delivery and
software</p>

<p><sup>(Meyer et al., 2021)</sup></p>

<p>programs for home use, are being explored.</p>

<p>.</p>

<p>5. Application of Recently Developed Voice Therapy Method</p>

<p>There are some voice therapy techniques which have exhibited a promise in
handling speech problems among PD sufferers.&nbsp;</p>

<p><sup>20 kg, impairment of gait and speech, cognitive decline &gt;2 years
following surgery) were severe or worse, at least possibly related to DBS and <span
class=SpellE>non reversible</span>. In PD 23.1% of the STN-stimulated patients
experienced non-reversible (or unknown reversibility) AEs that were at least
possibly related to DBS in the form of impaired speech or gait, depression,
weight gain, cognitive <span class=GramE>disturbances</span> or urinary
incontinence (severity was mild or moderate in 15 of 18 patients). Age and <span
class=SpellE>Hoehn&amp;Yahr</span> stage of STN-simulated PD patients, but not
preoperative motor impairment or response to levodopa, showed a weak
correlation (r = 0.24 and 0.22, respectively) with the number of <span
class=SpellE>AEs.ConclusionsDBS</span>-related AEs that were severe or worse
and non-reversible were only observed in PD (4 of 82 patients; 4.9%), but not
in other diseases. PD patients exhibited a significant risk for non-severe AEs
most of which also represented preexisting and progressive axial and non-motor
symptoms of PD. Mild gait and/or speech disturbances were rather frequent
complaints under VIM stimulation. GPI stimulation for dystonia could be applied
with negligible DBS-related side effects.&quot;,&quot;journal&quot;:&quot;<span
class=SpellE>Plos</span>
One&quot;,&quot;relevanceScore&quot;:0.54296875,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Buhmann et al., 2017)</sup></p>

<p>However, intensive voice therapy is believed to be an effective treatment
but may be difficult to access especially in a country like Libya.&nbsp;</p>

<p><sup>(McGinnis et al., 2013)</sup></p>

<p>Hence, <span class=GramE>a research</span> on the <span class=SpellE>vailability</span>
of smart phone based <span class=SpellE>vides</span> conference was done to
assess the possibility of delivering voice therapy for PD patients in
Malaysia.&nbsp;</p>

<p><sup>(Dhamija et al., 2023)</sup></p>

<p>The study employed the LSV program aimed at the vocal folds and respiratory
assistance.</p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>&nbsp;LSVT has had positive results wherein people got better at speaking <span
class=GramE>and also</span> increased their ability to swallow.&nbsp;In this
pilot study, we assessed improvements in swallowing and voice function in 8 PD
patients following LSVT therapy.&nbsp;However, speech therapy is essential for
dealing with laryngeal manifestations of PD that may result in communication
problems. &nbsp;It is an intensive treatment that is based on raising the voice
volume with training on it lasting just four weeks.&nbsp;Research has <span
class=GramE>demonstrated</span></p>

<p><sup>(Kara et al., 2017)</sup></p>

<p>improvements in a variety of areas including voice intensity, <span
class=GramE>swallowing</span></p>

<p>ability, muscle tone, facial movements etc.</p>

<p><sup>(Ferreira et al., 2022)</sup></p>

<p>&nbsp;Other modes of delivery,</p>

<p>including webcams and computerized <span class=GramE>home based</span>
therapy system are under</p>

<p><sup>(Marin et al., 2022)</sup></p>

<p>investigations.&nbsp;In summation, the utilization</p>

<p>of voice therapy techniques with particular emphasis on LSVT have been</p>

<p>demonstrated to be effective for speech difficulties related to PD. </p>

<p>More research needs to be done though to substantiate such findings <span
class=GramE>and also</span> investigate other options for</p>

<p><sup>(Castillo-Allendes et al., 2021)</sup></p>

<p>delivery.&nbsp;</p>

<p><sup>(Christmann et al., 2015)</sup></p>

<p>Voice therapy should be available and effective enough since it improves the
lives of people with PD by</p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>helping them learn how to speak more clearly.</p>

<p><span class=SpellE>ethicalconsedration</span>: It is important to ensure
that the delivery of voice therapy for PD patients is ethical, considering
factors such as patient consent, privacy, and security. In conclusion, the
utilization of voice therapy techniques, particularly the Lee Silverman Voice
Treatment, has shown promise in effectively treating speech difficulties
related to PD <sup>(<span class=SpellE>Junakovi&#263;</span> &amp; <span
class=SpellE>Telarovi&#263;</span>, 2021)</sup>.</p>

<p>6. Results and Findings from <span class=SpellE><span class=GramE>he</span></span>
Case Study The study aimed to assess the</p>

<p>effects of intensive voice therapy on speech deficits in Parkinson's disease</p>

<p><sup>(<span class=SpellE>Tomeh</span> et al., 2022)</sup></p>

<p>(PD). </p>

<p>The therapy was delivered to case adults with PD over a period of three
years, consisting of 3sessions <span class=SpellE>aweek</span> via smartphone
videoconference.</p>

<p>&nbsp;The focus of the therapy was to increase vocal loudness. Objective,
perceptual, and quality-of-life measures were used to assess the outcomes
before and after treatment.</p>

<p><sup>(Dhamija et al., 2023)</sup></p>

<p>The results showed <span class=SpellE>significantimprovements</span> in
speech deficits, including increased vocal loudness, improved articulation, and
enhanced communication skills. Additionally, participants reported increased
confidence and improved quality of life.</p>

<p><sup>(Masterson-Algar et al., 2017)</sup></p>

<p>The Lee Silverman Voice Treatment has been proven to be an effective and
intensive therapy for individuals with Parkinson's disease <span class=GramE>who</span></p>

<p>improvements in sound pressure level during sustained vowels and monologue. </p>

<p>Perceptual ratings also showed that participants exhibited improvements in
speech intelligibility and voice quality.</p>

<p><span class=SpellE><sup>parkinson</sup></span><sup> S
Disease&quot;,&quot;relevanceScore&quot;:0.33935546875,&quot;categoryFinished<span
class=GramE>&quot;:false</span>}'&gt;(Ueno et al., 2017)</sup></p>

<p>significant improvements in overall mean severity and loudness after
treatment.</p>

<p>Additionally, there were significant improvements in speech intelligibility
and</p>

<p><span class=GramE>@<sup>(</sup></span><sup>Fiori et al., 2022)</sup></p>

<p>Voice Handicap Index-10 scores post-treatment.</p>

<p>&nbsp;Overall, participants expressed <span class=GramE>high</span></p>

<p>satisfaction with the smartphone videoconference method.</p>

<p>These findings suggest that the</p>

<p>smartphone videoconference method is feasible for delivering intensive <span
class=GramE>voice</span></p>

<p>therapy to individuals with PD, leading to improvements in speech and <span
class=GramE>voice</span></p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>functions. However, further studies are needed to standardize the <span
class=GramE>system</span></p>

<p>protocol for optimal delivery of this novel treatment approach in <span
class=SpellE>libya</span>.</p>

<p>It is worth noting <span class=GramE>that</span></p>

<p>previous studies have demonstrated the efficacy of intensive voice therapy
in</p>

<p>improving various aspects of voice and speech in PD.</p>

<p>&nbsp;The Lee Silverman Voice Treatment (LSVT),</p>

<p><sup>(<span class=SpellE>Crispiatico</span> et al., 2022)</sup></p>

<p>@</p>

<p>which focuses on maximizing phonatory and respiratory functions through <span
class=GramE>tasks</span></p>

<p>that promote loud voice production, has shown significant improvements <span
class=GramE>in</span></p>

<p>glottic closure, vocal fold movements, sound pressure level, fundamental</p>

<p>frequency range, voice quality, and speech intelligibility.</p>

<p>While levodopa has been shown</p>

<p>to be effective for treating motor symptoms associated with PD, its effects
on</p>

<p>speech improvement <span class=GramE>remain</span> inconclusive. </p>

<p>Objective voice quality</p>

<p><sup>(Rizek et al., 2016)</sup></p>

<p>measurements have shown improvement after levodopa administration; however,</p>

<p>studies have reported mixed results using objective acoustic measures.</p>

<p>Overall, intensive voice</p>

<p>therapy has shown promising results for improving speech deficits in PD. It</p>

<p>provides a feasible option for individuals who may face challenges <span
class=GramE>accessing</span></p>

<p>traditional face-to-face therapy sessions due to limited availability of
specialized</p>

<p>therapists. Further research is needed to optimize and standardize the <span
class=GramE>delivery</span></p>

<p>of intensive voice therapy <span class=GramE>in order to</span> maximize its
effectiveness and benefits</p>

<p>for individuals with PD7. Discussion and Implications</p>

<p>The discussion and implications</p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>of the effects of intensive voice therapy on speech deficits in Parkinson's</p>

<p>disease can be interpreted based on the available data. </p>

<p>The Lee Silverman Voice</p>

<p>Treatment (LSVT) has been identified as an effective <span class=SpellE>behavioral</span>
<span class=GramE>intervention</span></p>

<p>approach for treating speech and vocal difficulties in patients with</p>

<p>Parkinson's disease (PD). </p>

<p>The treatment focuses on</p>

<p>improving vocal loudness and enhancing other vocal features.</p>

<p>Several studies have <span class=GramE>shown</span></p>

<p>positive results from LSVT, including improvements in vocal intensity,</p>

<p>fundamental frequency, and overall intelligibility. These improvements have</p>

<p>been observed both immediately after the intervention and up to one <span
class=GramE>year</span></p>

<p>post-treatment. The treatment effects are associated with large effect
sizes,</p>

<p>indicating a strong degree of practical significance.</p>

<p><sup>(<span class=SpellE>Büssing</span> et al., <span class=GramE>2008)(</span>Cheng
&amp; Su, 2020)</sup></p>

<p>It is worth noting that speech therapies focusing solely on speed and
articulation have presented limited effectiveness in improving the symptoms of
PD in the long term. However, LSVT stands out due to its specific features: it
targets the voice as the primary intervention target, it is a high-effort and
intensive therapy, and it emphasizes calibration to promote generalization and
long-term effects.</p>

<p><sup>(Mohseni et al., 2022)</sup></p>

<p>LSVT has been found to be more effective than respiration treatment alone
for improving vocal intensity and decreasing the impact of Parkinson's disease
on communication. The treatment seems to be particularly effective for
increasing speaking intensity during sustained vowel production. </p>

<p><sup>(Fujii &amp; Wan, 2014)</sup></p>

<p>This may be attributed to the focus on rescaling vocal effort during speech,
which recruits cognitive pathways aligned with direct activation pyramidal
pathways.</p>

<p><sup>(Arriaga et al., 2012)</sup></p>

<p>Considering future treatment options, it is important to address some
limitations of research on LSVT programs. Prognostic variables for treatment
response need to be better defined, taking into account factors such as
depression, dementia, <span class=SpellE><span class=GramE>orthopedic</span></span></p>

<p><sup>(Jiang et al., 2023)</sup></p>

<p>complications, and atypical PD. Additionally, future research should
investigate combined treatment approaches involving pharmacological, surgical,
and speech therapies.</p>

<p><sup>(<span class=SpellE>Hongli</span> et al., 2018)</sup></p>

<p>Overall, the results <span class=GramE>obtained</span></p>

<p>from case studies and randomized controlled trials support the effectiveness
of</p>

<p>intensive voice therapy like LSVT in mitigating speech deficits in patients
with PD. </p>

<p>The treatment shows promise <span class=SpellE>i</span> improving vocal
loudness and other vocal features, thereby positively <span class=GramE>impacting</span></p>

<p><sup>(<span class=SpellE>Fabron</span> et al., 2018)</sup></p>

<p>social interactions and quality of life for these individuals. Further
research</p>

<p>and implementation of combined treatment approaches are key considerations
for</p>

<p>future advancements in the field. </p>

<p>.</p>

<p>8. Conclusion</p>

<p>In conclusion, intensive <span class=SpellE>voicetherapy</span> has shown
promising effects on speech deficits in Parkinson's disease patients with
bilateral thalamotomy. </p>

<p>Studies have demonstrated improvements in vocal loudness, speech
intelligibility, and articulatory changes following intensive voice treatment
such as the Lee Silverman Voice Treatment (LSVT).</p>

<p><sup>(Prenger et al., <span class=GramE>2020)(</span>Butala et al., 2022)</sup></p>

<p>This high-effort and intensive therapy focuses on calibrating the voice and <span
class=GramE>has</span></p>

<p><sup>(McInerney et al., 2021)</sup></p>

<p>been found to have long-term effects on vocal features.</p>

<p>However, further research and development in this area are crucial. While
the LSVT has shown effectiveness in improving vocal loudness and other vocal
features, there is still a need to better define prognostic variables for
treatment response in individuals with various factors such as depression,
dementia, apathy, <span class=SpellE>orthopedic</span> complications,
dyskinesias, atypical PD, and post-DBS surgery. </p>

<p><sup>(<span class=SpellE>Hongli</span> et al., <span class=GramE>2018)<strong>research</strong></span>&quot;,&quot;relevanceScore&quot;:-0.8642578125,&quot;categoryFinished&quot;:false}'&gt;(Lvova
&amp; <span class=SpellE>Toropova</span>, 2019)</sup></p>

<p>Additionally, more studies are required to assess the effects of intensive
voice therapy on swallowing function in Parkinson's disease patients.</p>

<p>Speech therapy approaches that target speed and articulation have presented
limited effectiveness and unsuccessful long-term effects. Therefore, a <span
class=SpellE>behavioral</span> method like the LSVT focuses on intensity of
laryngeal function and emphasizes calibration <span class=GramE>appears</span></p>

<p><sup>(Dias et al., 2016)</sup></p>

<p>to be a more effective approach. The LSVT is an intensive intervention that <span
class=GramE>has</span></p>

<p>been shown to improve loudness and enhance other vocal features up to <span
class=GramE>several</span></p>

<p>months after treatment.</p>

<p>In summary, intensive voice</p>

<p>therapy shows promise in addressing speech deficits in Parkinson's <span
class=GramE>disease</span></p>

<p><sup>(Franzoi et al., 2018)</sup></p>

<p>patients with bilateral thalamotomy. However, further research is needed <span
class=GramE>to</span></p>

<p>better understand treatment outcomes in individuals with different
characteristics</p>

<p>and to explore the effects of intensive voice therapy on swallowing
function.</p>

<p><sup>(Franzoi et al., 2018)</sup></p>

<p>By continuing to study and develop evidence-based treatment programs like
the</p>

<p>LSVT, we can improve the quality of life for individuals with <span
class=GramE>Parkinson's</span></p>

<p>disease.</p>

<p>&nbsp;<span style='font-family:Inter;color:#1F2937;letter-spacing:.1pt'><o:p></o:p></span></p>

<p class=text-gray-500 style='margin:0in;background:white'><i><span
style='font-family:Inter;color:#1F2937;letter-spacing:-.05pt'>References.</span></i><span
style='font-family:Inter;color:#1F2937;letter-spacing:-.05pt'><o:p></o:p></span></p>

<ol start=1 type=1>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Ahlberg, E., Laakso, K., &amp; Hartelius, L. (2011,
     January 1). Perceived Changes in Communication as an Effect of STN Surgery
     in Parkinson's Disease: A Qualitative Interview Study.
     https://scite.ai/reports/10.4061/2011/540158</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Arriaga, G., Zhou, E P., &amp; Jarvis, E D. (2012,
     October 10). Of Mice, Birds, and Men: The Mouse Ultrasonic Song System Has
     Some Features Similar to Humans and Song-Learning Birds.
     https://scite.ai/reports/10.1371/journal.pone.0046610</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Boltežar, L., &amp; Bahar, M Š. (2014, October 15).
     Voice Disorders in Occupations with Vocal Load in Slovenia / <span
     class=SpellE>Glasovne</span> <span class=SpellE>Težave</span> V <span
     class=SpellE>Poklicih</span> Z <span class=SpellE>Glasovno</span> <span
     class=SpellE>Obremenitvijo</span> V <span class=SpellE>Sloveniji</span>.
     https://scite.ai/reports/10.2478/sjph-2014-0033</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Buhmann, C., <span class=SpellE>Huckhagel</span>,
     T., Engel, K., <span class=SpellE>Gulberti</span>, A., <span class=SpellE>Hidding</span>,
     U., Poetter-Nerger, M., <span class=SpellE>Goerendt</span>, I K., Ludewig,
     P., <span class=SpellE>Braaß</span>, H., Choe, C., Krajewski, K., <span
     class=SpellE>Oehlwein</span>, C., <span class=SpellE>Mittmann</span>, K.,
     Engel, A K., Gerloff, C., Westphal, M., <span class=SpellE>Köppen</span>,
     J., Moll, C K., &amp; Hamel, W. (2017, July 5). Adverse events in deep
     brain stimulation: A retrospective long-term analysis of neurological, <span
     class=GramE>psychiatric</span> and other occurrences.
     https://scite.ai/reports/10.1371/journal.pone.0178984</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Büssing</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     A., <span class=SpellE>Cysarz</span>, D., <span class=SpellE>Edelhäuser</span>,
     F., <span class=SpellE>Bornhöft</span>, G., Matthiessen, P F., &amp;
     Ostermann, T. (2008, December 1). The oil-dispersion bath in <span
     class=SpellE>anthroposophic</span> medicine – an integrative review.
     https://scite.ai/reports/10.1186/1472-6882-8-61</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Butala, A., Li, K., Swaminathan, A., Dunlop, S R.,
     Salnikova, Y., Ficek, B., Portnoff, B., Harper, M., Vernon, B., Turk, B
     R., Mari, Z., &amp; <span class=SpellE>Pantelyat</span>, A. (2022,
     September 20). <span class=SpellE>Parkinsonics</span>: A Randomized,
     Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms
     in Idiopathic Parkinson Disease.
     https://scite.ai/reports/10.1155/2022/4233203</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Castillo-Allendes, A., Contreras-Ruston, F., &amp;
     Searl, J. (2021, December 18). Auditory-vocal integration impairment: New
     challenges and opportunities for voice assessment and therapy.
     https://scite.ai/reports/10.46634/riics.62</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Chen, Q., Chen, B., Wan, Q., Wang, Y., Li, J.,
     &amp; Huang, Z. (2023, February 10). Effects of intensive speech treatment
     on Mandarin speakers with Parkinson’s Disease: A review.
     https://scite.ai/reports/10.1097/md.0000000000032900</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Cheng, Y., &amp; Su, C. (2020, April 22). Evidence
     Supports PA Prescription for Parkinson’s Disease: Motor Symptoms and
     Non-Motor Features: A Scoping Review.
     https://scite.ai/reports/10.3390/ijerph17082894</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Christmann, M K., <span class=SpellE>Brancalioni</span>,
     A R., Freitas, C R D., Vargas, D Z., Keske-Soares, M., <span class=SpellE>Mezzomo</span>,
     C L., &amp; Mota, H B. (2015, August 1). Uso do <span class=SpellE>programa</span>
     MDVP <span class=SpellE>em</span> <span class=SpellE>diferentes</span> <span
     class=SpellE>contextos</span>: <span class=SpellE>revisão</span> de <span
     class=SpellE>literatura</span>.
     https://scite.ai/reports/10.1590/1982-021620151742914</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Costa, F P D., <span class=SpellE>Diaferia</span>,
     G., &amp; <span class=SpellE>Behlau</span>, M. (2016, February 1). <span
     class=SpellE>Aspectos</span> <span class=SpellE>comunicativos</span> e <span
     class=SpellE>enfrentamento</span> da <span class=SpellE>disfonia</span> <span
     class=SpellE>em</span> <span class=SpellE>pacientes</span> com <span
     class=SpellE>doença</span> de Parkinson.
     https://scite.ai/reports/10.1590/2317-1782/20162015054</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Crispiatico</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     V., <span class=SpellE>Baldanzi</span>, C., Bertuletti, M., Grassi, S.,
     Tedeschi, F., <span class=SpellE>Groppo</span>, E., <span class=SpellE>Rovaris</span>,
     M., Cattaneo, D., &amp; Vitali, C. (2022, August 15). Factors Associated <span
     class=GramE>With</span> Treatment-Related Changes in Voice Volume in
     People With Multiple Sclerosis.
     https://scite.ai/reports/10.7224/1537-2073.2021-056</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Dankovicova</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     Z., <span class=SpellE>Sovák</span>, D., Drotar, P., &amp; <span
     class=SpellE>Vokorokos</span>, L. (2018, October 15). Machine Learning
     Approach to Dysphonia Detection.
     https://scite.ai/reports/10.3390/app8101927</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Dhamija, R., Saluja, A., &amp; Goyal, V. (2023,
     January 1). Multi-modal rehabilitation therapy in Parkinson's disease and
     related disorders. https://scite.ai/reports/10.4103/aian.aian_164_22</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Dias, A E., Limongi, J C P., Barbosa, E R., &amp;
     Hsing, W T. (2016, April 1). <span class=SpellE>Telerreabilitação</span>
     vocal <span class=SpellE>na</span> <span class=SpellE>doença</span> de
     Parkinson. https://scite.ai/reports/10.1590/2317-1782/20162015161</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Fabron</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     E M G., Silvério, K C A., <span class=SpellE>Berretin</span>-Felix, G.,
     Andrade, E C D., Salles, P F., Moreira, P A M., &amp; <span class=SpellE>Brasolotto</span>,
     A G. (2018, October 29). <span class=SpellE>Terapia</span> vocal para <span
     class=SpellE>idosos</span> com <span class=SpellE>progressão</span> de <span
     class=SpellE>intensidade</span>, <span class=SpellE>frequência</span> e <span
     class=SpellE>duração</span> do tempo de <span class=SpellE>fonação</span>:
     <span class=SpellE>estudo</span> de <span class=SpellE>casos</span>.
     https://scite.ai/reports/10.1590/2317-1782/20182017224</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Ferreira, D B D C., Furlan, R M <span class=SpellE>M</span>
     <span class=SpellE>M</span>., Frazão, Y S., &amp; Motta, A R. (2022,
     January 1). Speech pathology in facial aesthetics: effects of two
     strategies for the suprahyoid muscles.
     https://scite.ai/reports/10.1590/1982-0216/20222469622</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Fiani, B., Siddiqi, I., Lee, S C., &amp; Dhillon,
     L. (2020, September 21). Telerehabilitation: Development, Application, and
     Need for Increased Usage in the COVID-19 Era for Patients with Spinal
     Pathology. https://scite.ai/reports/10.7759/cureus.10563</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Fiori, S., <span class=SpellE>Ragoni</span>, C., <span
     class=SpellE>Podda</span>, I., <span class=SpellE>Chilosi</span>, A.,
     Amador, C., Cipriani, P., Guzzetta, A., &amp; <span class=SpellE>Sgandurra</span>,
     G. (2022, July 6). PROMPT to improve speech motor abilities in children
     with cerebral palsy: a wait-list control group trial protocol.
     https://scite.ai/reports/10.1186/s12883-022-02771-6</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Foltynie</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     T., &amp; Grover, T. (2020, July 1). Not only loud but also intelligible.
     https://scite.ai/reports/10.1016/j.eclinm.2020.100456</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Franzoi, A E D A., <span class=SpellE>Bonchoski</span>,
     A B., &amp; Koerbel, A. (2018, January 1). The advances of Deep Brain
     Stimulation (DBS) for treatment of Parkinson s disease (PD).
     https://scite.ai/reports/10.4322/2357-9730.86267</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Fujii, S., &amp; Wan, C Y. (2014, October 13). The
     Role of Rhythm in Speech and Language Rehabilitation: The SEP Hypothesis.
     https://scite.ai/reports/10.3389/fnhum.2014.00777</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Garg, D., &amp; Dhamija, R K. (2020, January 1). <span
     class=SpellE>Teleneurorehabilitation</span> for Parkinson's Disease: A
     Panacea for the Times to <span class=GramE>Come?.</span>
     https://scite.ai/reports/10.4103/aian.aian_566_20</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Goloborshcheva</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     V <span class=SpellE>V</span>., <span class=SpellE>Kucheryanu</span>, V
     G., Voronina, N A., Teterina, E V., <span class=SpellE>Ustyugov</span>, A <span
     class=SpellE>A</span>., &amp; Morozov, S G. (2022, September 14).
     Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta
     Dopaminergic Neurons.
     https://scite.ai/reports/10.3390/biomedicines10092278</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Hameed, Z., Rehman, W U., Khan, W., Ullah, N.,
     &amp; <span class=SpellE>Albogamy</span>, F R. (2021, December 9).
     Weighted Hybrid Feature Reduction Embedded with Ensemble Learning for
     Speech Data of Parkinson’s Disease.
     https://scite.ai/reports/10.3390/math9243172</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Haq, A U., Li, J P., Memon, M H., Khan, J., Malik,
     A., Ahmad, T., Ali, A., Nazir, S., Ahad, I., &amp; Shahid, M. (2019,
     January 1). Feature Selection Based on L1-Norm Support Vector Machine and
     Effective Recognition System for Parkinson’s Disease Using Voice
     Recordings. https://scite.ai/reports/10.1109/access.2019.2906350</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Hongli</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     L., Li, G., Liu, G., &amp; Zhang, Y. (2018, June 26). <span class=SpellE>Liuzijue</span>
     Qigong vs traditional breathing training for patients with post-stroke
     dysarthria complicated with abnormal respiratory control: study protocol
     of a single <span class=SpellE>center</span> randomized controlled trial.
     https://scite.ai/reports/10.1186/s13063-018-2734-0</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Jiang, F., Su, Y., &amp; Chang, T. (2023, March 2).
     Knowledge mapping of global trends for myasthenia gravis development: A
     bibliometrics analysis.
     https://scite.ai/reports/10.3389/fimmu.2023.1132201</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Junakovi&#263;</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     A., &amp; <span class=SpellE>Telarovi&#263;</span>, S. (2021, September
     1). The effects of art therapy on Parkinson`s and Alzheimer`s disease.
     https://scite.ai/reports/10.21860/medflum2021_261184</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Kara, M., Ertekin, H., Sahin, B., <span
     class=SpellE>Cevizci</span>, S., &amp; <span class=SpellE>Dereköy</span>,
     F S. (2017, April 25). <span class=SpellE>Larenks</span> <span
     class=SpellE>kanserli</span> <span class=SpellE>hastalarda</span> adjuvant
     <span class=SpellE>radyoterapinin</span> <span class=SpellE>ses</span> <span
     class=SpellE>ve</span> <span class=SpellE>ya&#351;am</span> <span
     class=SpellE>kalitesi</span> <span class=SpellE>ile</span> <span
     class=SpellE>ili&#351;kisi</span>.
     https://scite.ai/reports/10.22391/920.308837</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Kim, D Y., Oh, H M., Bok, S., Chang, W H., Choi,
     Y., Chun, M H., Han, S J., Han, T., Jee, S., Jung, S H., Jung, H Y., Jung,
     T., Kim, E J., Kim, H S., Kim, Y., Kim, Y., Kim, D Y., Kim, D Y., Kim, D.,
     . . . Yoo, W. (2020, January 1). KSNR Clinical Consensus Statements:
     Rehabilitation of Patients with Parkinson's Disease.
     https://scite.ai/reports/10.12786/bn.2020.13.e17</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Kulkarni, P., Duffy, O., Synnott, J., Kernohan, G.,
     &amp; McNaney, R. (2022, January 5). Speech and Language Practitioners’
     Experiences of Commercially Available Voice-Assisted Technology: Web-Based
     Survey Study. https://scite.ai/reports/10.2196/29249</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Lakshmi, S., <span class=SpellE>Jagadeeshwaran</span>,
     P., <span class=SpellE>AkashS</span>., <span class=SpellE>JananiK</span>.,
     &amp; <span class=SpellE>AkilandeswariD</span>. (2021, October 4).
     Discriminating Parkinson and Healthy People Using Machine Learning.
     https://scite.ai/reports/10.3233/apc210029</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Li, L., Wu, P., Qian, H., Xu, W., Shi, H., &amp;
     Jiang, J. (2022, July 29). Tailored Extracellular Vesicles: Novel Tool for
     Tissue Regeneration. https://scite.ai/reports/10.1155/2022/7695078</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Little, M A., Costello, D., &amp; Harries, M.
     (2009, April 21). Objective dysphonia quantification in vocal fold
     paralysis: comparing nonlinear with classical measures.
     https://scite.ai/reports/10.1038/npre.2009.3106.1</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Lvova</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     T V., &amp; <span class=SpellE>Toropova</span>, A V. (2019, May 9).
     Functional Expansion of Music Education Technologies (through the example
     of music rehabilitation therapy of neurology ward patients).
     https://scite.ai/reports/10.30564/jpr.v1i1.472</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Marin, A., DeCaro, R., <span class=SpellE>Schiloski</span>,
     K A., <span class=SpellE>Elshaar</span>, A., Dwyer, B., Vives-Rodriguez,
     A., Palumbo, R., Turk, K W., &amp; <span class=SpellE>Budson</span>, A E.
     (2022, September 12). Home-Based Electronic Cognitive Therapy in Patients <span
     class=GramE>With</span> Alzheimer Disease: Feasibility Randomized
     Controlled Trial. https://scite.ai/reports/10.2196/34450</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Masterson-Algar, P., Burton, C., Brady, M., Nicoll,
     A., Clarke, C E., Rick, C., Hughes, M., Au, P., Smith, C H., &amp; <span
     class=SpellE>Sackley</span>, C. (2017, August 29). The PD COMM trial: a
     protocol for the process evaluation of a randomised trial assessing the
     effectiveness of two types of SLT for people with Parkinson’s disease.
     https://scite.ai/reports/10.1186/s13063-017-2130-1</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>McGinnis, W R., <span class=SpellE>Audhya</span>,
     T., &amp; Edelson, S M. (2013, December 11). Proposed Toxic and Hypoxic
     Impairment of a Brainstem Locus in Autism.
     https://scite.ai/reports/10.3390/ijerph10126955</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>McInerney, M., <span class=SpellE>Imms</span>, C.,
     Carding, P., &amp; <span class=SpellE>Reddihough</span>, D. (2021,
     December 1). Evaluation of an intensive voice treatment to reduce anterior
     drooling in children with cerebral palsy: Protocol for a concurrent
     multiple-baseline, single case experimental design study.
     https://scite.ai/reports/10.1016/j.conctc.2021.100872</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Meyer, B., Utter, G., &amp; Hillman, C. (2021,
     October 8). A Personalized, Interactive, Cognitive <span class=SpellE>Behavioral</span>
     Therapy–Based Digital Therapeutic (MODIA) for Adjunctive Treatment of
     Opioid Use Disorder: Development Study.
     https://scite.ai/reports/10.2196/31173</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Mohseni, Z., Saffarian, A., Mohamadi, R., <span
     class=SpellE>Abolghasemi</span>, J., &amp; Habibi, S A H. (2022, November
     19). Effect of Conventional Speech Therapy Combined with Music Therapy on
     Swallowing in Patients with Parkinson's Disease (Telerehabilitation): A
     Randomized-Controlled Trial. https://scite.ai/reports/10.5812/mejrh-131572</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Nanahara</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     M., Yamamoto, K., &amp; Nakagawa, S. (2022, January 1). Correlation of
     acoustic features of pitch/rhythm/power and perceptual impressions after
     singing training for people with dysarthria.
     https://scite.ai/reports/10.1250/ast.43.22</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Ozker</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     M., Doyle, W., Devinsky, O., &amp; Flinker, A. (2022, February 3). A
     cortical network processes auditory error signals during human speech
     production to maintain fluency.
     https://scite.ai/reports/10.1371/journal.pbio.3001493</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Pellecchia, M T., Picillo, M., Santangelo, G.,
     Longo, K., Moccia, M., Erro, R., <span class=SpellE>Amboni</span>, M.,
     Vicidomini, C., Salvatore, M., Barone, P., &amp; <span class=SpellE>Pappatà</span>,
     S. (2015, February 3). Cognitive performances and DAT imaging in early
     Parkinson's disease with mild cognitive impairment: a preliminary study.
     https://scite.ai/reports/10.1111/ane.12365</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Perju-<span class=SpellE>Dumbrav&#259;</span>, L.,
     Lau, K., <span class=SpellE>Phyland</span>, D., Papanikolaou, V., Finlay,
     P N., Beare, R., Bardin, P G., Stuckey, S., Kempster, P., &amp;
     Thyagarajan, D. (2017, November 3). Arytenoid cartilage movements are
     hypokinetic in Parkinson’s disease: A quantitative dynamic computerised
     tomographic study. https://scite.ai/reports/10.1371/journal.pone.0186611</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Pfeifer, K J., Cook, A J., <span class=SpellE>Yankulova</span>,
     J K., Mortimer, B J P., Erickson-DiRenzo, E., Dhall, R., Montaser-<span
     class=SpellE>Kouhsari</span>, L., &amp; Tass, P A. (2021, November 18).
     Clinical Efficacy and Dosing of Vibrotactile Coordinated Reset Stimulation
     in Motor and Non-motor Symptoms of Parkinson's Disease: A Study Protocol.
     https://scite.ai/reports/10.3389/fneur.2021.758481</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Prenger, M T M., Madray, R., Hedger, K V., Anello,
     M., &amp; MacDonald, P A. (2020, December 31). Social Symptoms of
     Parkinson’s Disease. https://scite.ai/reports/10.1155/2020/8846544</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Rizek, P., Kumar, N., &amp; Jog, M. (2016, May 24).
     An update on the diagnosis and treatment of Parkinson disease.
     https://scite.ai/reports/10.1503/cmaj.151179</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Sackley</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     C., Rick, C., Au, P., Brady, M C., Beaton, G., Burton, C., Caulfield, M.,
     Dickson, S., Dowling, F., Hughes, M., Ives, N., Jowett, S.,
     Masterson-Algar, P., Nicoll, A., Patel, S., Smith, C H., Woolley, R.,
     &amp; Clarke, C E. (2020, May 27). A multicentre, randomised controlled
     trial to compare the clinical and cost-effectiveness of Lee Silverman
     Voice Treatment versus standard NHS Speech and Language Therapy versus
     control in Parkinson’s disease: a study protocol for a randomised
     controlled trial. https://scite.ai/reports/10.1186/s13063-020-04354-7</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Sackley</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     C., Smith, C H., Rick, C., Brady, M., Ives, N., Patel, R., Roberts, H.,
     Dowling, F., Jowett, S., Wheatley, K., Patel, S., Kelly, D., Sands, G.,
     &amp; Clarke, C E. (2014, June 7). Lee Silverman voice treatment versus
     standard NHS speech and language therapy versus control in Parkinson’s
     disease (PD COMM pilot): study protocol for a randomized controlled trial.
     https://scite.ai/reports/10.1186/1745-6215-15-213</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Scobie, S., Jowett, S., Lambe, T., Patel, S.,
     Woolley, R., Ives, N., Rick, C., Smith, C M., Brady, M C., Clarke, C E.,
     &amp; <span class=SpellE>Sackley</span>, C. (2021, August 9). Lee
     Silverman Voice Treatment versus standard speech and language therapy
     versus control in Parkinson’s disease: preliminary cost-consequence
     analysis of the PD COMM pilot randomised controlled trial.
     https://scite.ai/reports/10.1186/s40814-021-00888-y</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Seidel, U K., Gronewold, J., Wicking, M., &amp; <span
     class=SpellE>Bellebaum</span>, C. (2016, May 10). Vascular Risk Factors
     and Diseases Modulate Deficits of Reward-Based Reversal Learning in Acute
     Basal Ganglia Stroke.
     https://scite.ai/reports/10.1371/journal.pone.0155267</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Silveira, D N., &amp; <span class=SpellE>Brasolotto</span>,
     A G. (2005, August 1). <span class=SpellE>Reabilitação</span> vocal <span
     class=SpellE>em</span> <span class=SpellE>pacientes</span> com <span
     class=SpellE>doença</span> de Parkinson: <span class=SpellE>fatores</span>
     <span class=SpellE>interferentes</span>.
     https://scite.ai/reports/10.1590/s0104-56872005000200013</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Stevenson, S A., Ciucci, M R., &amp; Kelm-Nelson, C
     A. (2019, August 2). Intervention changes acoustic peak frequency and
     mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease.
     https://scite.ai/reports/10.1371/journal.pone.0220734</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Syed, Z S., Memon, S A., &amp; Memon, A L. (2020,
     January 1). Deep Acoustic Embeddings for Identifying Parkinsonian Speech.
     https://scite.ai/reports/10.14569/ijacsa.2020.0111089</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Tomeh</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     A., Khan, A H K Y., Mat, L N I., Basri, H., &amp; Sulaiman, W A W. (2022,
     June 10). Repetitive Transcranial Magnetic Stimulation of the Primary
     Motor Cortex beyond Motor Rehabilitation: A Review of the Current
     Evidence. https://scite.ai/reports/10.3390/brainsci12060761</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Udow</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     S., Freitas, M E., Fox, S H., &amp; Lang, A E. (2018, January 14).
     Exacerbation of psychosis triggered by a synthetic cannabinoid in a
     70-year-old woman with Parkinson disease.
     https://scite.ai/reports/10.1503/cmaj.170361</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Ueno, T., Sasaki, M., Nishijima, H., <span
     class=SpellE>Funamizu</span>, Y., Kon, T., Haga, R., Arai, A., Suzuki, C.,
     <span class=SpellE>Nunomura</span>, J., Baba, M., &amp; Tomiyama, M.
     (2017, January 1). LSVT-BIG Improves UPDRS III Scores at 4 Weeks in
     Parkinson’s Disease Patients with Wearing Off: A Prospective, Open-Label
     Study. https://scite.ai/reports/10.1155/2017/8130140</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Yang, S., Zheng, F., Luo, X., Cai, S., Wu, Y., Liu,
     K., Wu, M., Chen, J., &amp; Krishnan, S. (2014, February 20). Effective
     Dysphonia Detection Using Feature Dimension Reduction and Kernel Density
     Estimation for Patients with Parkinson’s Disease. https://scite.ai/reports/10.1371/journal.pone.0088825</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=indent--2rem><span style='font-family:Inter;
     letter-spacing:-.05pt'>Zahid, L., Maqsood, M., Durrani, M Y., Bakhtyar,
     M., Baber, J., Jamal, H., Mehmood, I., &amp; Song, O. (2020, January 1). A
     Spectrogram-Based Deep Feature Assisted Computer-Aided Diagnostic System
     for Parkinson’s Disease. https://scite.ai/reports/10.1109/access.2020.2974008</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
 <li class=MsoNormal style='color:#111827;mso-margin-top-alt:auto;mso-margin-bottom-alt:
     auto;line-height:normal;mso-list:l0 level1 lfo2;tab-stops:list .5in;
     background:white'><span class=SpellE><span class=indent--2rem><span
     style='font-family:Inter;letter-spacing:-.05pt'>Zvrko</span></span></span><span
     class=indent--2rem><span style='font-family:Inter;letter-spacing:-.05pt'>,
     E., &amp; Kadi&#263;, M. (2022, June 1). Validity, internal consistency,
     and test-retest reliability of the Montenegrin 10-item Voice Handicap
     Index. https://scite.ai/reports/10.2478/aiht-2022-73-3624</span></span><span
     style='font-family:Inter;letter-spacing:-.05pt'><o:p></o:p></span></li>
</ol>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

</div>

</body>

</html>
